Ethypharm is a leading mid-size international specialty pharmaceutical company, with strong European roots, that manufactures and provides essential medicines with a focus on Central Nervous System (severe pain and addiction) and Hospital Injectables.
Discover Ethypharm at a glance
At Ethypharm, our mission is to improve patients’ lives by providing essential medicines and making a positive impact on society and the environment.
Our products are treating:
– Severe pain
– Addiction
– Critical care situations
Ethypharm is deeply engaged in the Central Nervous System and Hospital Injectable areas, where our medicines treat patients and our teams work on innovative solutions for tomorrow. Willing to grow beyond our recognised positions in the treatment of severe pain and addiction, we are constantly screening opportunities in search for those which will respond to unmet needs in our two core areas.
Ethypharm is a rapidly evolving company with a clear strategy and significant growth ambitions.
Through strategic geographical expansions and commercial team committed to achieving great results, we’re dedicated to connecting with customers and making a meaningful impact in patients’lives in every market we enter.
We are open to discussing potential partnerships.
Get to know our business development (BD) teams and come discuss with us!
Medical Developments International enters licensing agreement for Penthrox® (methoxyflurane) distribution with Ethypharm in France
Saint-Cloud, France & Melbourne, Australia – 29 April 2025. Medical Developments International (ASX: MVP) and Ethypharm have entered into a licensing agreement for marketing and distribution of Penthrox® (methoxyflurane) in France. Penthrox® is an inhaled analgesic used across multiple countries for acute pain management. Under this agreement, Ethypharm will be responsible for the marketing and […]
Read moreEthypharm announces the appointment of Éric CHEVALIER as Group Human Resources Director
Saint-Cloud (France), Friday 4 October 2024 – Denis DELVAL, President & CEO of the Ethypharm Group, announces the appointment of Éric CHEVALIER as Group Human Resources Director with effect from 1 October 2024.
Read more